Caris Life Sciences Gets ISO 15189 Accreditation for Lab | GenomeWeb

NEW YORK (GenomeWeb News) – Caris Life Sciences today said that its tumor profiling lab in Phoenix, Ariz., has received ISO 15189 accreditation.

The accreditation was provided by the American Association for Laboratory Accreditation. The ISO 15189 standard covers qualifications and ongoing competency of the company's laboratory personnel, laboratory accommodation, equipment, reagents and supplies, pre-analytical and analytical factors, quality assurance considerations, and post-analytical factors, said Irving, Texas-based Caris.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.